Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Payments for (Proceeds from) Other Investing Activities

3.0 / 5 stars · 61/101 Roast Me

BIOMARIN PHARMACEUTICAL INC Payments for (Proceeds from) Other Investing Activities

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Payments for (Proceeds from) Other Investing Activities of -$4.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $0.00.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was -$4.97M.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was $0.00.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was $0.00.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for fiscal 2025 was $0.00.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for fiscal 2024 was -$1.14M.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for fiscal 2023 was $0.00.
  • BIOMARIN PHARMACEUTICAL INC payments for (proceeds from) other investing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endPayments for (Proceeds from) Other Investing Activities 3 monthPayments for (Proceeds from) Other Investing Activities 3 month as first filedPayments for (Proceeds from) Other Investing Activities 6 monthPayments for (Proceeds from) Other Investing Activities 6 month as first filedPayments for (Proceeds from) Other Investing Activities 9 monthPayments for (Proceeds from) Other Investing Activities 9 month as first filedPayments for (Proceeds from) Other Investing Activities 12 monthPayments for (Proceeds from) Other Investing Activities 12 month as first filed
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$4.97M
10-Q · filed 2026-08-06
-$4.97M
derived: sum of 3 quarters · filed 2026-08-06
-$4.97M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$4.97M
10-Q · filed 2026-05-05
-$4.97M
derived: sum of 2 quarters · filed 2026-05-05
-$4.97M
derived: sum of 3 quarters · filed 2026-05-05
-$4.97M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-08-06
$0.00
10-K · filed 2026-02-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$0.00
derived: sum of 2 quarters · filed 2026-08-06
$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$0.00
10-Q · filed 2026-08-06
$0.00
derived: sum of 3 quarters · filed 2026-08-06
2025-03-31$0.00
10-Q · filed 2026-05-05
$0.00
derived: sum of 2 quarters · filed 2026-05-05
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$1.14M
10-K · filed 2026-02-26
2024-09-30-$1.14M
10-Q · filed 2025-10-28
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2023-09-30$0.00
10-Q · filed 2024-10-31
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$0.00
derived: sum of 2 quarters · filed 2025-02-24
$0.00
10-K · filed 2025-02-24
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$0.00
10-Q · filed 2022-10-28
2022-06-30$0.00
10-Q · filed 2022-08-04
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$86.00K
derived: sum of 2 quarters · filed 2024-02-26
$994.00K
derived: sum of 3 quarters · filed 2024-02-26
$994.00K
10-K · filed 2024-02-26
2021-09-30$86.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$994.00K
derived: sum of 2 quarters · filed 2022-10-28
$994.00K
10-Q · filed 2022-10-28
$992.00K
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$908.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$908.00K
10-Q · filed 2022-08-04
$906.00K
derived: sum of 3 quarters · filed 2023-02-27
$909.00K
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$0.00
10-Q · filed 2021-04-30
-$2.00K
derived: sum of 2 quarters · filed 2023-02-27
$1.00K
derived: sum of 3 quarters · filed 2023-02-27
$388.00K
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$1.00K
derived: sum of 2 quarters · filed 2023-02-27
$388.00K
derived: sum of 3 quarters · filed 2023-02-27
$723.00K
10-K · filed 2023-02-27
2020-09-30$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$390.00K
derived: sum of 2 quarters · filed 2021-10-29
$725.00K
10-Q · filed 2021-10-29
-$214.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$387.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$722.00K
10-Q · filed 2021-07-30
-$217.00K
derived: sum of 3 quarters · filed 2022-02-25
$722.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$335.00K
10-Q · filed 2021-04-30
-$604.00K
derived: sum of 2 quarters · filed 2022-02-25
$335.00K
derived: sum of 3 quarters · filed 2022-02-25
$1.07M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$939.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$0.00
derived: sum of 2 quarters · filed 2022-02-25
$740.00K
derived: sum of 3 quarters · filed 2022-02-25
$808.00K
10-K · filed 2022-02-25
2019-09-30$939.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$1.68M
derived: sum of 2 quarters · filed 2020-11-06
$1.75M
10-Q · filed 2020-11-06
$1.75M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$740.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$808.00K
10-Q · filed 2020-08-05
$808.00K
derived: sum of 3 quarters · filed 2021-02-26
-$23.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$68.00K
10-Q · filed 2020-05-01
$1.77M
10-Q · filed 2019-04-29
$68.00K
derived: sum of 2 quarters · filed 2021-02-26
-$763.00K
derived: sum of 3 quarters · filed 2021-02-26
-$21.00K
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
-$831.00K
derived: sum of 2 quarters · filed 2021-02-26
-$89.00K
derived: sum of 3 quarters · filed 2021-02-26
$10.00K
10-K · filed 2021-02-26
2018-09-30-$831.00K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
-$89.00K
derived: sum of 2 quarters · filed 2019-11-04
$10.00K
10-Q/A · filed 2019-11-04
$203.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$742.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$841.00K
10-Q · filed 2019-08-02
$1.03M
derived: sum of 3 quarters · filed 2020-02-27
$1.03M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$99.00K
10-Q · filed 2019-04-29
$292.00K
derived: sum of 2 quarters · filed 2020-02-27
$292.00K
derived: sum of 3 quarters · filed 2020-02-27
$461.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$193.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$193.00K
derived: sum of 2 quarters · filed 2020-02-27
$362.00K
derived: sum of 3 quarters · filed 2020-02-27
$1.75M
10-K · filed 2020-02-27
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$169.00K
derived: sum of 2 quarters · filed 2018-10-26
$1.56M
10-Q · filed 2018-10-26
$2.11M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$169.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$1.56M
10-Q · filed 2018-08-03
$2.11M
derived: sum of 3 quarters · filed 2019-02-28
$2.11M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$1.39M
10-Q · filed 2018-04-27
$1.94M
derived: sum of 2 quarters · filed 2019-02-28
$1.94M
derived: sum of 3 quarters · filed 2019-02-28
$1.94M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$548.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$548.00K
derived: sum of 2 quarters · filed 2019-02-28
$548.00K
derived: sum of 3 quarters · filed 2019-02-28
$698.00K
10-K · filed 2019-02-28
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$0.00
derived: sum of 2 quarters · filed 2017-10-31
$150.00K
10-Q · filed 2017-10-31
$3.48M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$150.00K
10-Q · filed 2017-08-02
$3.48M
derived: sum of 3 quarters · filed 2018-02-26
2016-03-31$150.00K
10-Q · filed 2017-05-04
$3.48M
derived: sum of 2 quarters · filed 2018-02-26
2015-12-31$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$3.33M
10-K · filed 2018-02-26
$0.00
10-K · filed 2017-02-27
2015-09-30$0.00
10-Q · filed 2016-11-03
2015-03-31$1.03M
10-Q · filed 2016-05-02
$1.03M
derived: sum of 2 quarters · filed 2017-02-27
$2.63M
derived: sum of 3 quarters · filed 2017-02-27
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$1.60M
derived: sum of 2 quarters · filed 2017-02-27
$3.10M
10-K · filed 2017-02-27
$2.00M
10-K · filed 2015-03-02
2014-09-30$1.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$3.10M
10-Q · filed 2015-11-02
$2.00M
10-Q · filed 2014-10-28
2014-06-30$1.50M
10-Q · filed 2015-08-05
$1.00M
10-Q · filed 2014-07-31
2013-12-31$885.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$885.00K
derived: sum of 2 quarters · filed 2016-02-29
$885.00K
10-K · filed 2016-02-29
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
$0.00
10-Q · filed 2014-10-28
2013-06-30$0.00
10-Q · filed 2014-07-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05